Kiora Pharmaceuticals (KPRX) Short Interest Ratio & Short Volume $3.73 -0.01 (-0.27%) (As of 02:28 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Kiora Pharmaceuticals Short Interest DataKiora Pharmaceuticals (KPRX) has a short interest of 46,700 shares, representing 1.76% of the float (the number of shares available for trading by the public). This marks a 1,197.22% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 74,272 shares to cover all short positions.Current Short Interest46,700 sharesPrevious Short Interest3,600 sharesChange Vs. Previous Month+1,197.22%Dollar Volume Sold Short$168,120.00Short Interest Ratio1.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares2,970,000 sharesFloat Size2,660,000 sharesShort Percent of Float1.76%Today's Trading Volume15,279 sharesAverage Trading Volume74,272 sharesToday's Volume Vs. Average21% Short Selling Kiora Pharmaceuticals? Sign up to receive the latest short interest report for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKPRX Short Interest Over TimeKPRX Days to Cover Over TimeKPRX Percentage of Float Shorted Over Time Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Kiora Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202446,700 shares $168,120.00 +1,197.2%1.8%1.7 $3.60 10/15/20243,600 shares $11,520.00 -12.2%0.1%0.2 $3.20 9/30/20244,100 shares $15,006.00 -21.2%0.2%0.2 $3.66 9/15/20245,200 shares $19,032.00 -13.3%0.2%0.2 $3.66 8/31/20246,000 shares $22,200.00 -34.8%0.2%0.2 $3.70 8/15/20249,200 shares $29,900.00 -32.4%0.3%0.2 $3.25 Get the Latest News and Ratings for KPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202413,600 shares $62,968.00 -24.4%0.5%0.4 $4.63 7/15/202418,000 shares $74,880.00 -55.5%0.7%0.5 $4.16 6/30/202440,400 shares $169,680.00 +11.6%1.5%1.2 $4.20 6/15/202436,200 shares $194,032.00 +116.8%1.3%1.1 $5.36 5/31/202416,700 shares $74,097.90 -74.9%0.6%0.7 $4.44 5/15/202466,500 shares $34,247.50 -50.7%0.3%0.3 $0.52 4/30/2024135,000 shares $68,850.00 +83.9%0.6%0.5 $0.51 4/15/202473,400 shares $41,104.00 +48.3%0.3%0 $0.56 3/31/202449,500 shares $34,947.00 -42.7%0.7%0 $0.71 3/15/202486,400 shares $55,218.24 +51.6%1.2%0.1 $0.64 2/29/202457,000 shares $38,247.00 -65.4%0.8%0 $0.67 2/15/2024164,500 shares $103,914.65 -53.0%2.2%0.1 $0.63 1/31/2024349,800 shares $193,229.52 -2.3%5.0%0.2 $0.55 1/15/2024358,100 shares $189,649.76 +1.9%5.1%4 $0.53 12/31/2023351,300 shares $183,519.12 -7.1%5.0%3.7 $0.52 12/15/2023378,300 shares $203,147.10 -18.0%5.4%3.8 $0.54 11/30/2023461,100 shares $238,527.03 -14.6%6.6%4.5 $0.52 11/15/2023539,900 shares $312,008.21 +67.3%7.8%4.7 $0.58 10/31/2023322,700 shares $191,683.80 +15.0%4.9%1.1 $0.59 10/15/2023280,600 shares $179,291.90 +4.9%4.3%1 $0.64 9/30/2023267,400 shares $151,802.98 +5.9%4.1%0.9 $0.57 9/15/2023252,600 shares $136,151.40 -30.6%3.8%0.8 $0.54 8/31/2023364,200 shares $179,113.56 +398.9%5.4%1 $0.49 8/15/202373,000 shares $40,880.00 -17.9%1.0%0.2 $0.56 7/31/202388,900 shares $52,451.00 No Change1.3%0.3 $0.59 7/15/202388,900 shares $56,451.50 +15.9%1.3%0.3 $0.64 6/30/202376,700 shares $49,310.43 -37.4%1.3%0.3 $0.64 6/15/2023122,500 shares $98,000.00 -33.4%2.2%0.6 $0.80 5/31/2023183,900 shares $386,190.00 +99.9%3.3%1.1 $2.10 5/15/202392,000 shares $216,200.00 +0.7%5.2%1.3 $2.35 4/30/202391,400 shares $405,816.00 +13.4%5.4%0.1 $4.44 4/15/202380,600 shares $334,627.02 -15.0%4.7%0.1 $4.15 3/31/202394,800 shares $316,632.00 +96.3%5.6%0.1 $3.34 3/15/202348,300 shares $178,227.00 -66.6%2.9%0 $3.69Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover 2/28/2023144,500 shares $643,025.00 -53.5%8.7%0.1 $4.45 2/15/2023310,600 shares $1.69 million +354.8%18.7%0.2 $5.45 1/31/202368,300 shares $241,099.00 -47.1%4.3%0 $3.53 1/15/2023129,000 shares $476,010.00 +737.7%8.2%0.5 $3.69 12/30/202215,400 shares $52,822.00 -34.2%1.1%0 $3.43 12/15/202223,400 shares $79,326.00 -18.8%2.5%0 $3.39 11/30/202228,800 shares $102,240.00 -51.0%3.1%0.1 $3.55 11/15/202258,800 shares $363,384.00 -30.6%6.4%0.1 $6.18 10/31/202284,700 shares $556,479.00 +3.4%9.8%0.1 $6.57 10/15/202281,900 shares $504,504.00 -42.7%9.2%0.1 $6.16 9/30/2022142,800 shares $878,220.00 -97.6%N/A0.4 $6.15 9/15/20225,900,000 shares $1.33 million -16.7%N/A0.6 $0.22 8/31/20227,080,000 shares $1.38 million +1,993.4%45.6%0.8 $0.19 8/15/2022338,200 shares $52,421.00 +545.4%6.2%0.1 $0.16 7/31/202252,400 shares $7,708.04 -70.2%0.5%0.1 $0.15 7/15/2022176,000 shares $46,745.60 +25.6%1.4%0.3 $0.27 6/30/2022140,100 shares $65,931.06 -23.0%1.2%0.5 $0.47 6/15/2022182,000 shares $66,430.00 -3.9%1.5%0.6 $0.37 5/31/2022189,400 shares $83,336.00 No Change1.6%0.5 $0.44 5/15/2022189,400 shares $84,756.50 -9.5%1.6%0.6 $0.45 4/30/2022209,200 shares $110,876.00 +60.9%1.8%0.7 $0.53 4/15/2022130,000 shares $77,350.00 -23.0%1.1%0.4 $0.60 3/31/2022168,900 shares $105,123.36 -12.0%1.4%0.4 $0.62 3/15/2022191,900 shares $112,645.30 +54.0%1.6%0.1 $0.59 2/28/2022124,600 shares $77,875.00 -13.5%1.0%0 $0.63 2/15/2022144,000 shares $99,748.80 -1.2%1.2%0.1 $0.69 1/31/2022145,700 shares $112,189.00 -33.7%1.3%0.1 $0.77 1/15/2022219,900 shares $191,313.00 +362.0%2.1%0.1 $0.87 12/31/202147,600 shares $71,876.00 No Change0.5%0 $1.51 KPRX Short Interest - Frequently Asked Questions What is Kiora Pharmaceuticals' current short interest? Short interest is the volume of Kiora Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 46,700 shares of KPRX short. 1.76% of Kiora Pharmaceuticals' shares are currently sold short. Learn More on Kiora Pharmaceuticals' current short interest. What is a good short interest ratio for Kiora Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KPRX shares currently have a short interest ratio of 2.0. Learn More on Kiora Pharmaceuticals's short interest ratio. What is a good short interest percentage for Kiora Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.76% of Kiora Pharmaceuticals' floating shares are currently sold short. Is Kiora Pharmaceuticals' short interest increasing or decreasing? Kiora Pharmaceuticals saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 46,700 shares, an increase of 1,197.2% from the previous total of 3,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Kiora Pharmaceuticals' float size? Kiora Pharmaceuticals currently has issued a total of 2,970,000 shares. Some of Kiora Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kiora Pharmaceuticals currently has a public float of 2,660,000 shares. How does Kiora Pharmaceuticals' short interest compare to its competitors? 1.76% of Kiora Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kiora Pharmaceuticals: ProPhase Labs, Inc. (0.81%), Clene Inc. (2.91%), Passage Bio, Inc. (3.21%), CalciMedica, Inc. (1.36%), OKYO Pharma Limited (1.11%), NextCure, Inc. (0.31%), Lumos Pharma, Inc. (1.54%), Lexaria Bioscience Corp. (1.72%), Lantern Pharma Inc. (2.06%), Surrozen, Inc. (1.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Kiora Pharmaceuticals stock? Short selling KPRX is an investing strategy that aims to generate trading profit from Kiora Pharmaceuticals as its price is falling. KPRX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kiora Pharmaceuticals? A short squeeze for Kiora Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KPRX, which in turn drives the price of the stock up even further. How often is Kiora Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KPRX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies PRPH Short Interest CLNN Short Interest PASG Short Interest CALC Short Interest OKYO Short Interest NXTC Short Interest LUMO Short Interest LEXX Short Interest LTRN Short Interest SRZN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KPRX) was last updated on 11/12/2024 by MarketBeat.com Staff From Our PartnersAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredOptions Trading on Bitcoin?SEC Approves Crypto Options Trading Select altcoins poised for RAPID growth by early 2025… Crypto 101 Media | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | SponsoredCritical warning from the mountains of CarolinaNvidia CEO Jensen Huang says Big Tech will spend over $1 trillion on data centers. And that still might not...Weiss Ratings | SponsoredCrypto’s FINAL Wealth MomentBitcoin’s final bull market is here. If you missed out on the gains in 2017, or 2021… 2025 stands to be jus...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiora Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiora Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
